Clinical Trials Browser

Phase 2 × Ovarian Neoplasms × pazopanib × Clear all

NCT01610206 2021-02-25

A Randomized Study of Safety and Efficacy of Pazopanib and Gemcitabine in Persistent or Relapsed Ovarian Cancer

Phase 2 Completed

148 enrolled 11 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms, Recurrence

NCT01392352 2020-02-13

HYPAZ

Phase 2 Terminated

31 enrolled

BreastCNSDermatologicGastrointestinalGenitourinaryGynecologicSarcomaThoracic

Breast Neoplasms, Carcinoma, Non-Small-Cell Lung, Carcinoma, Renal Cell, Uterine Cervical Neoplasms, Gastrointestinal Neoplasms, Glioblastoma, Hypertension, Melanoma, Ovarian Neoplasms, Pancreatic Neoplasms, Sarcoma, Small Cell Lung Carcinoma

NCT00281632 2018-09-17

A Phase II, Open-Label Study Evaluating the Effect Of GW786034 In Subjects With Ovarian Cancer

Phase 2 Completed

35 enrolled 24 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT01644825 2018-04-09

MITO-11

Phase 2 Completed

72 enrolled

Gynecologic

Ovarian Neoplasms

NCT01227928 2015-03-03

Efficacy and Safety of Pazopanib Monotherapy After First-line Chemotherapy in Ovarian, Fallopian Tube, or Primary Peritoneal Cancer in Asian Women

Phase 2 Completed

145 enrolled 19 charts

Gynecologic

Fallopian Tube Neoplasms, Ovarian Neoplasms

NCT00561795 2012-03-22

Feasibility Study of Pazopanib in Combination With Chemotherapy in Gynaecological Tumors

Phase 2 Completed

12 enrolled 6 charts

Gynecologic

Carcinoma, Ovarian Epithelial, Uterine Cervical Diseases, Neoplasms, Ovarian Neoplasms, Uterine Diseases